• O NAMA

Welcome

Forgot password?

Not a member? Join today

Logo
  • Početna
  • Bolesti
    • Hronična limfocitna leukemija
    • Non hočkinski limfom
    • Hočkinski limfom
    • Leukemije
      • AML
      • ALL
  • Edukacija
    • Prezentacije
      • HLL
      • NHL
      • HL
    • Kvizovi
      • HLL
      • NHL
      • HL
  • Stil života
    • Zdraviji recepti
    • Fizička aktivnost
    • Prevencija
    • Korisni saveti
  • Resursi
    • Video
    • Brošure
    • Infografike
  • Blog
  • English
  • Početna
  • Bolesti
    • Hronična limfocitna leukemija
    • Non hočkinski limfom
    • Hočkinski limfom
    • Leukemije
      • AML
      • ALL
  • Edukacija
    • Prezentacije
      • HLL
      • NHL
      • HL
    • Kvizovi
      • HLL
      • NHL
      • HL
  • Stil života
    • Zdraviji recepti
    • Fizička aktivnost
    • Prevencija
    • Korisni saveti
  • Resursi
    • Video
    • Brošure
    • Infografike
  • Blog
  • English
13 Apr 2018
  • maja
  • Hočkinov limfom, Hronična limfocitna leukemija, Nehočkinski limfom

NIH study revises molecular classification for most common type of lymphoma

NIH study revises molecular classification for the most common type of lymphoma   Subgroups of DLBCL by gene expression (left) defined

Read More

16 Jan 2018
  • maja
  • Uncategorized

How does lymphoma affect the sleep quality and overall quality of life of long-term survivors?

How does lymphoma affect the sleep quality and overall quality of life of long-term survivors? This study analyzed the long-term effects of

Read More

14 Dec 2017
  • maja
  • Nehočkinski limfom

Subcutaneous vs intravenous rituximab treatment for patients with diffuse large B-cell lymphoma

Subcutaneous vs intravenous rituximab treatment for patients with diffuse large B-cell lymphoma Diffuse large B-cell lymphoma (DLBCL) is a common

Read More

14 Nov 2017
  • maja
  • Hronična limfocitna leukemija

Liver dysfunction at diagnosis can impact survival

Liver dysfunction at diagnosis can impact survival This study examined whether the presence of liver dysfunction affects the outcomes of newly

Read More

14 Nov 2017
  • maja
  • Hronična limfocitna leukemija

Immune disorder and infection risk in patients with early-stage CLL

Immune disorder and infection risk in patients with early-stage CLL This paper studied hypogammaglobulinemia, an immune disorder, in patients

Read More

  • 1
  • 2
  • 3
  • 4
  • 5

Pretraga

Najnoviji postovi

  • Evaluating the risk of developing acute myeloid leukemia or myelodysplastic syndrome after a stem cell transplant
  • Hodgkin Lymphoma Above and Below the Diaphragm: Are The Outcomes Different?
  • Chlorambucil, rituximab and lenalidomide combination treatment for patients with chronic lymphocytic leukemia
  • Evaluating the safety of ibrutinib in leukemia and lymphoma
  • Diffuse large B-cell lymphoma: 10 years’ real-world clinical experience with rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisolone

Arhiva

  • October 2018
  • April 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017

Kalendar

October 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
« Oct    

Categories

  • Hočkinov limfom (3)
  • Hronična limfocitna leukemija (9)
  • Nehočkinski limfom (4)
  • Uncategorized (8)

Novosti

Follow Us

Izradu platforme podržala kompanija

KONTAKT

Udruženje LIPA
+ 381 60 0 222 317
majaklipa@gmail.com
www.lipa.org.rs

Budite u toku sa najnovijim dešavanjima. Prijavite se

© Copyright LIPA 2017